Skip to Content
MoleculesMolecules
  • Review
  • Open Access

2 March 2018

Chemical and Biological Significance of Oenothein B and Related Ellagitannin Oligomers with Macrocyclic Structure

,
and
1
College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime 790-8578, Japan
2
Okayama University, Okayama 701-1152, Japan
*
Author to whom correspondence should be addressed.

Abstract

In 1990, Okuda et al. reported the first isolation and characterization of oenothein B, a unique ellagitannin dimer with a macrocyclic structure, from the Oenothera erythrosepala leaves. Since then, a variety of macrocyclic analogs, including trimeric–heptameric oligomers have been isolated from various medicinal plants belonging to Onagraceae, Lythraceae, and Myrtaceae. Among notable in vitro and in vivo biological activities reported for oenothein B are antioxidant, anti-inflammatory, enzyme inhibitory, antitumor, antimicrobial, and immunomodulatory activities. Oenothein B and related oligomers, and/or plant extracts containing them have thus attracted increasing interest as promising targets for the development of chemopreventive agents of life-related diseases associated with oxygen stress in human health. In order to better understand the significance of this type of ellagitannin in medicinal plants, this review summarizes (1) the structural characteristics of oenothein B and related dimers; (2) the oxidative metabolites of oenothein B up to heptameric oligomers; (3) the distribution of oenotheins and other macrocyclic analogs in the plant kingdom; and (4) the pharmacological activities hitherto documented for oenothein B, including those recently found by our laboratory.

1. Introduction

Antioxidant polyphenols in medicinal plants, foods, and fruits are currently acknowledged as important beneficial constituents that reduce the risk of life-related diseases closely associated with active oxygen damage, such as cancers, arteriosclerosis, diabetes, and coronary heart diseases, and have been explored as plausible chemopreventive agents for the human healthcare market. Polyphenols have thus received increasing attention for the discovery and development of their new physiological functions. Among various types of antioxidant plant polyphenols are low molecular weight compounds, represented by flavonoids and lignans, and higher molecular weight polyphenols classified as tannins. Vegetable tannins are classified into two large groups: (1) condensed tannins (proanthocyanidin polymers and oligomers); and (2) hydrolysable tannins, which are subgrouped into gallotannins (polygalloyl esters of glucose) and ellagitannins, which are characterized as hexahydroxydiphenoyl (HHDP) esters of sugar, mostly glucose, as represented by geraniin (1), tellimagrandin I (2), and II (3). In contrast to condensed tannins and gallotannins (Turkish or Chinese gall), which were long recognized in the leather industry [1], ellagitannins in medicinal plants had been little studied before the discovery of geraniin (1) from a Japanese folk medicine, Geranium thunbergii (Geraniaceae), by Okuda’s group in 1976 [2,3]. Since 1976, remarkable progress in the field of ellagitannin chemistry, promoted by the development of high resolution NMR and MS spectrometers and new separation methods, has led to the isolation and characterization of more than 500 ellagitannins with diverse arrays of structures from the traditional medicines long used in Japan, China, and South East Asia. The structural diversity of the ellagitannins are brought by various oxidative modifications of the HHDP group producing dehydroellagitannins, such as 1 or by intermolecular C‒O oxidative coupling(s) among multiple molecules, leading to oligomeric ellagitannins [4,5,6,7]. The first dimeric ellagitannin encountered in nature was agrimoniin from Agrimonia pilosa (Rosaceae), which was characterized as a dimer of potentillin (1-O-galloyl-2,3/4,6-di-O-(S)-HHDP-α-d-glucose), produced through the formation of a dehydrodigalloyl linking unit by intermolecular C‒O oxidative coupling between two galloyl groups at C-1 [8]. Among the more than 300 oligomers, up to heptamer, reported after the discovery of agrimoniin, oenothein B (4) is a unique macrocyclic ellagitannin dimer, which is biogenetically produced by double C‒O couplings of two molecules of tellimagrandin I (2), as illustrated in Figure 1.
Figure 1. Structures of geraniin (1), tellimagrandin I (2), and II (3), oenothein B (4), woodfordin C (5), eugeniflorin D1 (6), cuphiin D2 (7), cuphiin D1 (8), and oenothein C (9).
Oenothein B (4) was first isolated as a major component from the leaves of Oenothera erythrosepala (Onagraceae) in 1990 [9], and later found widely distributed in other plant species belonging to Myrtaceae and Lythraceae, as well as Onagraceae [5,6,10,11]. It was an important leading compound that made easier the structure elucidation of analogous oligomers co-occurring in various plant species. Furthermore, oenothein B and related oligomers have been reported to exhibit a variety of in vitro or in vivo physiological activities beneficial to human health.
This review summarizes the structural characteristics of oenothein B (4) and related oxidized metabolites, up to heptameric oligomer, found in medicinal plants and their diverse biological functions hitherto reported, including those discovered recently in our laboratory. This review provides a better understanding of the significance of those antioxidant tannin constituents in medicinal plants, which may lead to future developments of preventive or therapeutic agents for various chronic diseases associated with oxygen stress by active oxygen species and free radicals.

2. Structural Characteristics of Oenothein B

Oenothein B (4), FABMS m/z 1569 [M + H]+, was obtained as an amorphous powder forming an inseparable mixture of theoretically four anomers at two C-1 unacylated glucosyl cores, which caused extreme difficulty in its structure elucidation by spectroscopic analysis. In fact, the 1H-NMR spectrum in acetone-d6-D2O recorded at ambient temperature is poorly informative due to severe broadening and multiplication of each proton signal. This spectral feature is characteristic of this type of macrocyclic oligomers owing to the anomerization at each glucose core, and also to a poor flexibility of the macro ring arising from a restricted rotation around the ether linkages of two valoneoyl groups. The structure determination of 4 was performed by spectral and chemical methods, briefly described below.
The 1H-NMR measurement at an elevated temperature (40‒50 °C) provided a more informative spectrum, indicating the presence of a predominant anomer with anomeric proton signals at δ 6.20 (d, J = 3.5 Hz) and δ 4.48 (d, J = 7.5 Hz), due to the α- and β-anomers of glucose-I and II, respectively; however, some of the aromatic and sugar proton signals still broadened, probably due to the poor flexibility of the macro ring. A conclusive clue for the structure elucidation of 4 was brought by the NaBH4 reduction at the anomeric centers, which gave a sole tetrahydro derivative with two glucitol cores showing a well-resolved simple NMR spectrum. The spectrum clearly indicated the presence of two each of valoneoyl, galloyl, and glucitol groups as components, as revealed by the characteristic six 1H-singlets and two 2H-singlets in the aromatic region. These units were chemically substantiated by acid hydrolysis of 4, which produced glucose, and by permethylation followed by methanolysis, which afforded methyl tri-O-methylgallate and trimethyl (S)-octa-O-methylvaloneate in a 1:1 molar ratio. The binding modes of the valoneoyl and galloyl groups on the glucose cores in 4 were determined from the long-range 1H‒13C shift correlation spectrum of the tetrahydro derivative and identification of partial hydrolysates, including oenothein C (9), obtained upon treatment of 4 with hot water. The 13C-NMR and CD (large positive Cotton effect at 218‒236 nm) spectra of oenothein B were all consistent with the gross structure (4) [9] (Figure 1).
It is noteworthy that the purity of oenothein B (4) is hard to assess by reversed-phase HPLC, because of the appearance of multiple peaks on the chromatograph, depending on the different ratio of the anomers. The LC-MS/MS data for oenothein B reported by Toth et al. might be valuable for its identification [11]. Although expensive, oenothein B is now commercially available as analytical standard, and thus can be used as reference compound for the identification of oenothein B isolated from natural sources, by comparisons of the normal and reversed-phases HPLC with those of the commercial reagent.
Among interesting analogs of oenothein B (4) are oenotheins D (10) and F (11), which were isolated together with 4 (major principle) from the leaves of Oenothera laciniata, and characterized as regioisomers of 4, differing at the binding site of the valoneoyl group linking each monomeric unit, as illustrated in Figure 2 [12]. Contrary to oenothein B (4), oenothein D (10) displayed a well-resolved 1H-NMR spectrum at ambient temperature, and indicated the presence of predominant anomers at each glucose core, as revealed by the unacylated anomeric proton signals at δ 5.89 (d, J = 4 Hz; glucose-I) and 4.85 (d, J = 8 Hz; glucose-II). The positions of the two valoneoyl moieties in 10 were determined in a similar way to 4, i.e., long-range 1H‒13C correlation spectrum and partial degradation in hot water.
Figure 2. Structures of oenotheins D (10) and F (11).
The 1H-NMR spectrum of oenothein F (11) in acetone-d6-D2O (2 drops) indicated that it exists as a mixture of four anomers at the glucose cores, as shown by the valoneoyl 1H- and galloyl 2H-singlets, each forming four lines in a ratio of ca. 1:2:2:6. It is noteworthy that the relative peak intensity of the four lines for each proton signal changed to ca. 1:4:4:23 after leaving the NMR sample in solution for two days. The 1H-NMR spectrum of the most dominant anomer looked like that of a monomeric tannin, namely the appearance of three singlets (δ 6.21, 6.40, and 7.30, each 2H) and one singlet (δ 7.04, 4H) assignable to two valoneoyl and two galloyl units. The sugar proton signals were also apparently those of a monomeric tannin closely similar to those of an α-anomer of tellimagrandin I (2). Such a monomer-like 1H-NMR spectrum suggested that 11 has a symmetrical structure with a considerably flexible macro ring (Figure 2).
Oenothein B (4) and related dimers were also found in plant species of Lythraceae and Myrtaceae, as well as Oenotheraceae. Notably, the lythraceous and myrtaceous plants, unlike Oenotheraceae, produce the galloylated oenothein B together with 4. Woodfordin C (5) and eugeniflorin D1 (6), which are monogalloyl isomers at glucose-I of 4, were obtained from Woodfordia fruticosa (Lythraceae), a popular traditional Jamu medicine in Indonesia and Malaysia [13,14], and Eugenia uniflora (Myrtaceae), an evergreen fruit tree called Brazilian cherry [15], respectively. The 1H-NMR spectrum of 5 (α-gallate at glucose-I), recorded at ambient temperature, displayed broad signals for some of the aromatic and glucose protons, while the spectrum recorded at an elevated temperature (38 °C), which largely contributed to its structure elucidation, was much simpler, and displayed a preferred β-anomer at glucose-II [anomeric proton, δ 4.38 (br. d, J = 8 Hz)] [13]. Cuphiin D2 (7), a β-gallate at glucose-II of 4, was isolated along with a digallate, cuphiin D1 (8), as well as 4 and 5 from the aerial parts of Cuphea hyssopifolia (Lythraceae), which has been used as a folk medicine for treating stomach disorders and oral contraceptive in South and Central Americas [16]. The existence of a dominant α-anomer at glucose-I in 7 (δ 6.18, d, J = 3 Hz) was evidenced by the absence of duplicates of any proton signal in the NMR spectra recorded at 40 °C, and also the observation of a single peak in the reversed-phase HPLC. The structural relationship of cuphiins D1 (8) and D2 (7) was verified by enzymatic degalloylation of 8, with tannase affording 4, 5, and 7, besides gallic acid (Figure 1).

3. Oxidized Metabolites (Dimers and Oligomers) of Oenothein B

An old hypothetical biogenesis of ellagitannins [1,4,17] has now been proven by the intensive enzymatic studies of Gross et al. Using crude enzyme preparations from the Tellima grandiflora leaves, they demonstrated the in vitro biosynthesis of ellagitannins, which includes an intramolecular C‒C oxidative coupling of pentagalloylglucose to tellimagrandin II (3) [18], followed by an oxidative intermolecular C‒O coupling between two moles of 3 to yield a dimeric ellagitannin, cornusiin E (12) [19] (Figure 3). These in vitro C‒C and C‒O couplings in the biosynthesis of hydrolysable tannins are thought to occur in vivo through free radical coupling processes involving laccase-type phenolase, with a lower redox potential than those concerned in lignification processes.
Figure 3. in vitro biosynthesis of cornusiin E (12) from tellimagrandin II (3) (2 moles).
Similar intermolecular oxidative coupling(s) of oenothein B and related dimers with additional monomeric ellagitannin(s) are believed to lead to trimeric and higher oligomeric analogs. Such examples in nature are oenothein A (13) from Oenothera and Epilobium species, and its gallate, woodfordins D (14) (trimer) [20], E (15) (trimer) and F (16) (tetramer), together with woodfordin I (17) (dimer) from the W. fruticosa flowers [21]. The presence of oenothein B-related oligomers larger than 16 in Epilobium angustifolium (willowherb) was recently reported by Salminen et al. [22]. They isolated the oenothein B-based oligomers using preparative HPLC, and characterized them as oenothein B (4), oenothtein A (13), woodfordin F (16), and related pentameric (18) to heptameric (20) oligomers, chiefly based on the analysis of the fragmentation pattern in the ESI-microTOF-Q mass spectra (negative mode) (Figure 4). The structures of these oligomers were postulated as those produced by the formation of the valoneoyl group through sequential intermolecular oxidative coupling(s) of a galloyl unit at C2 of monomeric tellimagrandin I (2) with an HHDP unit of the terminal glucose-IV of woodfordin F (16). In the mass spectra, basic fragmentation occurred reversely through the sequential removal of a molecule of tellimagrandin I (2) by the oxidative cleavage of an ether bond of the valoneoyl unit from the terminal glucose core, leading to a fragment ion due to the remaining HHDP (o-quinone) ester part(s). Quantitative analyses of individual oligomers in the extracts of flowers, leaves, and stems of E. angustifolium were successfully performed by ultra-high performance liquid chromatography coupled with tandem mass spectra (UHLC-MS/MS) [22,23]. This analytical method was reported to offer the advantages of good repeatability and sensitivity for an accurate quantification of this class of oligomers, with limits of detection ranging from 0.1 to 1.3 μg/mL.
Figure 4. Structures of oenothein A (13), woodfordins D (14), E (15), and F (16), pentamer (18), hexamer (19), and heptamer (20), Structures of woodfordin I (17) and woodfordinic acid (21).
Woodfordinic acid (21), which is the parent acid participating in the linkage of three glucose cores (I–III) in oenothein A (13) and woodfordin D (14), was characterized as a gallic acid tetramer by spectral analyses (NMR, MS, and CD) of its methylated derivative (21a; C42H46O20) obtained upon permethylation of 14 followed by methanolysis [21]. Its symmetrical structure was evidenced by 2 aromatic proton singlets and 7 methoxy proton signals, and 21 carbon signals comprising of 12 sp2, 2 ester carbonyl and 7 sp3 carbon signals in the 1H- and 13C-NMR spectra, respectively (Figure 4). Woodfordin I (17), a dimer possessing the woodfordinoyl group, is likely a catabolic metabolite of 13 and 14. Interestingly, woodfordin I was also isolated from a traditional Chinese medicine, Chamaenerion (= Epilobium) angustifolium [24].
Analogs eugeniflorin D2 (22), and oenotherin T1 (23) and T2 (24), all containing an oxidized valoneoyl group, were found in Eugenia uniflora [15] and O. tetraptera [25,26], respectively. The structural confirmation of oenotherin T1 (23) was conducted by the Na2S2O4 reduction of the isodehydrovaloneoyl group affording oenothein A (13), similar to the conversion of a dehydrohexahydroxyl group to an HHDP group [3]. Notably, in contrast to many Oenothera species producing mainly oenothein A (13) and B (4), the most abundant constituent of O. tetraptera was oenotherin T1. On the other hand, eugeniflorin D2 (22), with a dehydrovaloneoyl group isomeric to that in oenotherin T1 (23), was also found in the leaves of Eucalyptus cypellocarpa [27] and Myrtus communis of Myrtaceae [28]. Eurobustin C (25), isolated from Eucalyptus robusta [6], as well as oenotherin T2 (24), had a new unique linking unit in place of the valoneoyl group, as shown in Figure 5.
Figure 5. Structures of eugeniflorin D2 (22), oenotherins T1 (23), T2 (24), and eurobustin C (25).
In a study on the production of ellagitannins by callus cultures, Taniguchi et al. reported the establishment of callus tissues induced from the Oenothera laciniata leaves, which yielded large amounts of oenotheins A (13) and B (4), as well as oenotherin T1 (23) [25,29]. It is noteworthy that oenothein B content (65 mg/g dry wt) in the calli cultured on modified Linsmaier–Skoog’s medium was 1.8 times higher than that of intact leaves [29].

4. Distribution of Oenothein B and Its Analogs

As described earlier, oenotheins A (13) and B (4) have been isolated as main ingredients accompanying various analogs from the plant species of Onagraceae, Lythraceae, and Myrtaceae [5,10,11,20,30,31]. The distribution of oenothein B (4) in further species of these plant families was examined by HPLC to reveal its considerable wide occurrence, particularly in Eucalyptus species of Myrtaceae [30,32]. The oenothein B-containing plants reported so far are summarized in Table 1. Recently, the dried pericarps of Punica granatum belonging to Lythraceae (Punicaceae) were reported to produce oenothein B, along with new tellimagrandin I-based linear oligomers, pomegraniin A (tetramer) (28) and B (pentamer) (29), as well as eucalbanin B (dimer) (26) and eucarpanin T1 (trimer) (27), which were first isolated from the leaves of Eucalyptus alba [33] and E. cypellocarpa [27] (Myrtaceae), respectively [34] (Figure 6). Although in the classical plant taxonomy Punicaceae belonged to its own family, it is currently included in the Lythraceae family in the phylogenetic system APG III [35]. It is chemotaxonomically interesting that the oligomeric ellagitannins of P. granatum showed close resemblance with those of the genera Cuphea, Lythrus, and Woodfordia, which are closely related genera in this family [36], although P. granatum is distinguished from the species of the other genera in the elongation mode of the monomers; that is, the presence of an oenothein B-based trimer (13) in the latter three, or absence in the former.
Table 1. Distribution of oenothein B and related macrocyclic oligomers in plants.
Figure 6. Structures of eucalbanin B (26), eucarpanin T1 (27), pomegraniin A (tetramer) (28), and B (pentamer) (29).

6. Conclusions

Since the discovery in 1990 of oenothein B (4) and woodfordin C (5), a unique class of dimeric ellagitannins with macrocyclic structures, many analogous ellagitannins (oenotheins, woodfordins, cuphiins, eugeniflorins, and oenotherins), including oxidized oligomers up to heptamer with molecular weight 5488, have been isolated from various medicinal plants belonging to Onagraceae, Lythraceae, and Myrtaceae. Their novel structures were elucidated by spectroscopic analyses (ESIMS, 1D and 2D NMR, CD) and chemical degradation. Oenothein B is commonly the most abundant constituent in plants containing this class of macrocyclic ellagitannins.
Oenothein B (4) and its analogs were documented to possess diverse in vitro and in vivo pharmacological properties, including antioxidants, antitumor, immunomodulatory, and antimicrobial effects, and their potencies were, in general, much higher than those of the related polyphenols with small molecular weight, suggesting the necessity of the entire structure of tannins for exhibiting activities. Hence, this type of oligomer may provide promising leads for the development of novel therapeutics and chemopreventive agents. An often-claimed problem is that high molecular weight tannins (polyphenols) have a limited bioavailability in biological systems due to their low solubility, stability, and membrane permeability. Therefore, biological activities of tannins and related polyphenols found in in vitro and in vivo assays have to be interpreted with caution, as noted in many papers or reviews, for the necessity of further studies. Increased interest for the fate of ellagitannins in the gastrointestinal tract has thus prompted investigations on the bioavailability or actual metabolites of ellagitannins in detail [55,56,57,81,82,86], and these aspects were reviewed by Tomas-Barberan et al. [87] and Torronen [88]. On the other hand, an oral delivery device, which encapsulates oenothein B or other ellagitannins, was reported for their enhanced protection through the gastrointestinal tract [89]. Further studies on these matters, including different manners of intestinal metabolism from those of non-macrocyclic ellagitannins, are strongly encouraged, for a better understanding and effective usage of these bioactive macrocyclic ellagitannins.

Author Contributions

T.Y., M.Y. and Y.A. contributed equally to this work and T.Y. finalized the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Haslam, E. The metabolism of gallic and hexahydroxydiphenic acid in higher plant. Fortschr. Chem. Org. Naturstoffe 1982, 41, 1–46. [Google Scholar]
  2. Okuda, T.; Yoshida, T.; Hatano, T. Geraniin, a new ellagitannin from Geranium thunbergii. Tetrahedron Lett. 1976, 17, 3721–3724. [Google Scholar] [CrossRef]
  3. Okuda, T.; Yoshida, T.; Hatano, T. Constituents of Geranium thunbergii Sieb. et Zucc. Part 12. Hydrated stereostructure and equilibration of geraniin. J. Chem. Soc. Perkin Trans. 1 1982, 9–14. [Google Scholar] [CrossRef]
  4. Okuda, T.; Yoshida, T.; Hatano, T. Hydrolyzable tannins and related polyphenols. Prog. Chem. Organ. Nat. Prod. 1995, 66, 1–117. [Google Scholar]
  5. Yoshida, T.; Amakura, Y.; Yoshimura, M. Structural Features and Biological Properties of Ellagitannins in the Myrtales. Int. J. Mol. Sci. 2010, 11, 79–106. [Google Scholar] [CrossRef] [PubMed]
  6. Yoshida, T.; Hatano, T.; Ito, H.; Okuda, T. Highly Oxidized Ellagitannins and Their Biological Activity. In Plant Polyphenols 2; Gross, G.G., Hemingway, R.W., Yoshida., T., Eds.; Kluwer/Plenum: New York, NY, USA, 1999; pp. 127–144. [Google Scholar]
  7. Okuda, T.; Yoshida, T.; Hatano, T.; Ito, H. Ellagitannins Renewed the Concept of Tannins. In Chemistry and Biology of Ellagitannins; Quideau, S., Ed.; World Scientific: Hackensack, NJ, USA, 2009; pp. 1–54. [Google Scholar]
  8. Okuda, T.; Yoshida, T.; Kuwahara, M.; Memon, M.; Shingu, T. Agrimoniin and potentillin, ellagitannin dimer and monomer having α-glucose cores. J. Chem. Commun. 1982, 163–164. [Google Scholar] [CrossRef]
  9. Hatano, T.; Yasuhara, T.; Matsuda, M.; Yazaki, K.; Yoshida, T.; Okuda, T. Oenothein B, a Dimeric, hydrolysable tannin with macrocyclic structure, and accompanying tannins from Oenothera erythrosepala. J. Chem. Soc. Perkin Trans. 1 1990, 2735–2743. [Google Scholar] [CrossRef]
  10. Ducrey, B.; Marston, A.; Göhring, S.; Hartmann, R.W.; Hostettmann, K. Inhibition of 5α-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species. Planta Med. 1997, 63, 111–114. [Google Scholar] [CrossRef] [PubMed]
  11. Tóth, B.H.; Blazics, B.; Kéry, A. Polyphenol composition and antioxidant capacity of Epilobium species. J. Pharm. Biomed. Anal. 2009, 49, 26–31. [Google Scholar] [CrossRef] [PubMed]
  12. Yoshida, T.; Chou, T.; Shingu, T.; Okuda, T. Oenotheins D, F and G, Hydrolysable Tannin Dimers from Oenothera laciniata. Phytochemistry 1995, 40, 555–561. [Google Scholar] [CrossRef]
  13. Yoshida, T.; Chou, T.; Nitta, A.; Miyamoto, K.; Koshiura, R.; Okuda, T. Woodfordin C, a macro-ring hydrolyzable tannin dimer with antitumor activity, and accompanying dimers from Woodfordia fruticosa flowers. Chem. Pharm. Bull. 1990, 38, 1211–1217. [Google Scholar] [CrossRef] [PubMed]
  14. Kadota, S.; Takamori, Y.; Nyein, K.N.; Kikuchi, T.; Tanaka, K.; Ekimoto, H. Constituents of the leaves of Woodfordia fruticosa Kurz. I. Isolation, structure, and proton and carbon-13 nuclear magnetic resonance signal assignments of woodfruticosin (woodfordin C), an inhibitor of deoxyribonucleic acid topoisomerase II. Chem. Pharm. Bull. 1990, 38, 2687–2697. [Google Scholar] [CrossRef] [PubMed]
  15. Lee, M.; Nishimoto, S.; Yang, L.L.; Yen, K.Y.; Hatano, T.; Yoshida, T.; Okuda, T. Two macrocyclic hydrolysable tannin dimers from Eugenia uniflora. Phytochemistry 1997, 44, 1343–1349. [Google Scholar]
  16. Chen, L.G.; Yen, K.Y.; Yang, L.L.; Hatano, T.; Okuda, T.; Yoshida, T. Macrocyclic ellagitannin dimers, cuphiins D1 and D2, and accompanying tannins from Cuphea hyssopifolia. Phytochemistry 1999, 50, 307–312. [Google Scholar] [CrossRef]
  17. Haddock, E.A.; Gupta, R.K.; Al-Shafi, S.M.K.; Layden, K.; Haslam, E.; Magnolato, D. The Metabolism of gallic acid and hexahydroxydiphenic acid in plants; biogenetic and molecular taxonomic considerations. Phytochemistry 1982, 21, 1049–1062. [Google Scholar] [CrossRef]
  18. Niemetz, R.; Schilling, G.; Gross, G.G. Ellagitannin Biosynthesis: Oxidation of pentagalloylglucose to tellimagrandin II by an emzyme from Tellima grandiflora leaves. Chem. Commun. 2001, 1, 35–36. [Google Scholar] [CrossRef]
  19. Niemetz, R.; Schilling, G.; Gross, G.G. Biosynthesis of dimeric ellagitannin, cornusiin E, in Tellima grandiflora. Phytochemistry 2003, 64, 109–114. [Google Scholar] [CrossRef]
  20. Yoshida, T.; Chou, T.; Matsuda, M.; Yasuhara, T.; Yazaki, K.; Hatano, T.; Nitta, A.; Okuda, T. Woodfordin D and oenothein A, trimeric hydrolyzable tannins of macro-ring structure with antitumor activity. Chem. Pharm. Bull. 1991, 39, 1157–1162. [Google Scholar] [CrossRef] [PubMed]
  21. Yoshida, T.; Chou, T.; Nitta, A.; Okuda, T. Tannins and related polyphenols of lythraceous plants. III. Hydrolyzable tannin oligomers with macrocyclic structure and accompanying tannins from Woodfordia fruticosa KURTZ. Chem. Pharm. Bull. 1992, 40, 2023–2030. [Google Scholar] [CrossRef]
  22. Baert, N.; Karonen, M.; Salminen, J.P. Isolation, characterization and quantification of the main oligomeric macrocyclic ellagitannins in Epilobium angustifolium by ultra-high performance chromatography with diode array detection and electrospray tandem mass spectrometry. J. Chromatogr. A 2015, 1419, 26–36. [Google Scholar] [CrossRef] [PubMed]
  23. Baert, N.; Kim, J.; Karonen, M.; Salminen, J.P. Inter-population and inter-organ distribution of the main polyphenolic compounds of Epilobium angustifolium. Phytochemistry 2017, 134, 54–63. [Google Scholar] [CrossRef] [PubMed]
  24. Liu, M.J.; Wang, Z.; Li, H.X.; Wu, R.C.; Liu, Y.Z.; Wu, Q.Y. Mitochondrial dysfunction as an early event in the process of apoptosis induced by woodfordin I in human leukemia K562 cells. Toxicol. Appl. Pharmacol. 2004, 194, 141–155. [Google Scholar] [CrossRef] [PubMed]
  25. Taniguchi, S.; Imayoshi, Y.; Yabu-uchi, R.; Ito, H.; Hatano, T.; Yoshida, T. A macrocyclic ellagitannin trimer, oenotherin T1, from Oenothera species. Phytochemistry 2002, 59, 191–195. [Google Scholar] [CrossRef]
  26. Taniguchi, S.; Imayoshi, Y.; Yoshida, T.; Hatano, T. A new trimeric hydrolysable tannin, oenotherin T2, isolated from aerial parts of Oenothera tetraptera Cav. Heterocyles 2009, 79, 617–626. [Google Scholar]
  27. Yoshida, T.; Hatano, T.; Ito, H. Chemistry and function of vegetable polyphenols with high molecular weights. BioFactors 2000, 13, 121–125. [Google Scholar] [CrossRef] [PubMed]
  28. Yoshimura, M.; Amakura, Y.; Tokuhara, M.; Yoshida, T. Polyphenolic compounds isolated from the leaves of Myrtus communis. J. Nat. Med. 2008, 62, 366–368. [Google Scholar] [CrossRef] [PubMed]
  29. Taniguchi, S.; Nakamura, N.; Nose, M.; Takeda, S.; Yabu-uchi, R.; Ito, H.; Yoshida, T.; Yazaki, K. Production of macrocyclic ellagitannin oligomers by Oenothera laciniata callus cultures. Phytochemistry 1998, 48, 981–985. [Google Scholar] [CrossRef]
  30. Amakura, Y.; Yoshimura, M.; Sugimoto, N.; Yamazaki, T.; Yoshida, T. Marker constituents of the natural antioxidant Eucalyptus leaf extract for the evaluation of food additives. Biosci. Biotechnol. Biochem. 2009, 73, 1060–1065. [Google Scholar] [CrossRef] [PubMed]
  31. Okuda, T.; Yoshida, T.; Hatano, T.; Yazaki, K.; Kira, R.; Ikeda, Y. Chromatography of tannins II: Preparative fractionation of hydrolyzable tannins by centrifugal partition chromatography. J. Chromatogr. A 1986, 362, 375–381. [Google Scholar] [CrossRef]
  32. Santos, S.C.; Waterman, P.G. Polyphenols from Eucalyptus consideniana and Eucalyptus viminalis. Fitoterapia 2001, 72, 95–97. [Google Scholar] [CrossRef]
  33. Yoshida, T.; Maruyama, T.; Nitta, A.; Okuda, T. Eucalbanins A, B and C, monomeric and dimeric hydrolyzable tannins from Eucalyptus alba REINW. Chem. Pharm. Bull. 1992, 40, 1750–1754. [Google Scholar] [CrossRef]
  34. Ito, H.; Li, P.; Koreishi, M.; Nagatomo, A.; Nishida, N.; Yoshida, T. Ellagitannin oligomers and a neolignan from pomegranate arils and their inhibitory effects on the formation of advanced glycation end products. Food Chem. 2014, 152, 323–330. [Google Scholar] [CrossRef] [PubMed]
  35. The Angiosperm Phylogeny Group. An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants. APG III. Bot. J. Linn. Soc. 2009, 161, 105–121. [Google Scholar]
  36. Graham, S.A.; Hall, J.; Sytsma, K.; Shi, S. Phylogenetic analysis of the Lythraceae based on four gene regions and morphology. Int. J. Plant Sci. 2005, 166, 995–1017. [Google Scholar] [CrossRef]
  37. Granica, S.; Czerwińska, M.E.; Piwowarski, J.P.; Ziaja, M.; Kiss, A.K. Chemical composition, antioxidative and anti-inflammatory activity of extracts prepared from aerial parts of Oenothera biennis L. and Oenothera paradoxa Hudziok obtained after seeds cultivation. J. Agric. Food Chem. 2013, 30, 801–810. [Google Scholar] [CrossRef] [PubMed]
  38. Kiss, A.K.; Kapłon-Cieślicka, A.; Filipiak, K.J.; Opolski, G.; Naruszewicz, M. Ex vivo effects of an Oenothera paradoxa extract on the reactive oxygen species generation and neutral endopeptidase activity in neutrophils from patients after acute myocardial infarction. Phytother. Res. 2012, 26, 482–487. [Google Scholar] [CrossRef] [PubMed]
  39. Granica, S.; Piwowarski, J.P.; Czerwińska, E.M.; Kiss, A.K. Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): A review. J. Ethnopharmacol. 2014, 156, 316–346. [Google Scholar] [CrossRef] [PubMed]
  40. Lee, M.H.; Chiou, J.F.; Yen, K.Y.; Yang, L.L. EBV DNA polymerase inhibition of 4 tannins from Eugenia uniflora. Cancer Lett. 2000, 54, 131–136. [Google Scholar] [CrossRef]
  41. Yoshida, T.; Hatano, T.; Ito, H.; Okuda, T. Structural diversity and antimicrobial activities of ellagitannins. In Chemistry and Biology of Ellagitannins; Quideau, S., Ed.; World Scientific: Hackensack, NJ, USA, 2009; pp. 55–93. [Google Scholar]
  42. Dobreva, M.A.; Green, R.J.; Muller-Harvey, I.; Salminen, J.P.; Howlin, B.J.; Frazier, R.A. Size and molecular flexibility affect the binding of ellagitannins to bovine serum albumin. J. Agric. Food Chem. 2014, 62, 9186–9194. [Google Scholar] [CrossRef] [PubMed]
  43. Schepetkin, I.A.; Ramstead, A.G.; Kirpotina, L.N.; Voyich, J.M.; Jutila, M.A.; Quinn, M.T. Therapeutic potential of polyphenols from Epilobium angustifolium (Fireweed). Phytother. Res. 2016, 30, 1287–1297. [Google Scholar] [CrossRef] [PubMed]
  44. Jassen, Y.M.V.; Van Houten, B.; Borm, P.J.A.; Mossman, B.T. Cell and tissue responses to oxidative damage. Lab. Investig. 1993, 69, 261–274. [Google Scholar]
  45. Haslam, E. Natural polyphenols (vegetable tannins) as drugs: possible models of action. J. Nat. Prod. 1996, 59, 205–215. [Google Scholar] [CrossRef] [PubMed]
  46. Okuda, T.; Yoshida, T.; Hatano, T. Pharmacologically active tannins isolated from medicinal plants. In Plant Polyphenols; Hemingway, R.W., Lacks, P.E., Eds.; Plenum Press: New York, NY, USA, 1992; pp. 530–569. [Google Scholar]
  47. Fujita, Y.; Komagoe, K.; Sasaki, Y.; Uehara, I.; Okuda, T.; Yoshida, T. Inhibition mechanism of tannins on Cu(II)-catalyzed autoxidation of ascorbic acid. Yakugaku Zasshi 1987, 107, 17–22. [Google Scholar] [CrossRef]
  48. Yoshida, T.; Mori, K.; Hatano, T.; Okumura, T.; Uehara, I.; Komagoe, K.; Fujita, Y.; Okuda, T. Radical-scavenging effects of tannins and related polyphenols on 1,1-diphenyl-2-picrylhydrazyl radical. Chem. Pharm. Bull. 1989, 37, 1919–1921. [Google Scholar] [CrossRef]
  49. Hagerman, A.E.; Riedl, K.M.; Rice, R.E. Tannins as biological antioxidants. In Plant Polyphenols 2; Gross, G.G., Hemingway, R.W., Yoshida, T., Eds.; Kluwer Academic/Plenum Publishers: New York, NY, USA, 1999; pp. 495–505. [Google Scholar]
  50. Hagerman, A.E.; Riedl, K.M.; Jones, G.A.; .Sovik, K.N.; Ritchard, N.T.; Hartzfeld, P.W.; Riechel, T.L. High molecular weight plant polyphenolics (Tannins) as biological antioxidants. J. Agric. Food Chem. 1998, 46, 1887–1892. [Google Scholar] [CrossRef] [PubMed]
  51. Kiss, A.K.; Bazylko, A.; Filipek, A.; Granica, S.; Jaszewska, E.; Kiarszys, U.; Kośmider, A.; Piwowarski, J.P. Oenothein B’s contribution to the anti-inflammatory and antioxidant activity of Epilobium sp. Phytomedicine 2011, 18, 557–560. [Google Scholar] [CrossRef] [PubMed]
  52. Wang, C.C.; Chen, L.G.; Yang, L.L. Antitumor activity of four macrocyclic ellagitannins from Cuphea hyssopifolia. Cancer Lett. 1999, 140, 195–200. [Google Scholar] [CrossRef]
  53. Wang, C.C.; Chen, L.G.; Yang, L.L. Cytotoxic effects of cuphiin D1 on the growth of human cervical carcinoma and normal cells. Anticancer Res. 2002, 22, 2677–2684. [Google Scholar] [PubMed]
  54. Sakagami, H.; Jiang, Y.; Kusama, K.; Atsumi, T.; Ueha, T.; Toguchi, M.; Iwakura, I.; Satoh, K.; Ito, H.; Hatano, T.; et al. Cytotoxic activity of hydrolyzable tannins against human oral tumor cell lines---A possible mechanism. Phytomedicine 2000, 7, 39–47. [Google Scholar] [CrossRef]
  55. Kiss, A.; Kowalski, J.; Melzig, M.F. Induction of neutral endopeptidase activity in PC-3 cell by aqueous extract of Epilobium angustifolium and Oenothein B. Phytomedicine 2006, 13, 284–289. [Google Scholar] [CrossRef] [PubMed]
  56. Piwowarski, J.P.; Bobrowska-Korczak, B.; Stanislawska, I.; Bielecki, W.; Wrzesien, R.; Granica, S.; Krupa, K.; Kiss, A.N. Evaluation of the effect of Eepilobium angustifolium aqueous extract on LNCap cell proliferation in in vitro and in vivo medels. Planta Med. 2017, 83, 1159–1168. [Google Scholar] [PubMed]
  57. Piwowarski, J.P.; Granica, S.; Stefarska, J.; Kiss, A.K. Differences in metabolism of ellagitannins by human gut microbiota ex vivo cultures. J. Nat. Prod. 2016, 79, 3022–3030. [Google Scholar] [CrossRef] [PubMed]
  58. Kuramochi-Motegi, A.; Kuramochi, H.; Kobayashi, F.; Ekimoto, H.; Takahashi, K.; Kadota, S.; Takamori, Y.; Kikuchi, T. Woodfruticosin (woodfordin C), a new inhibitor of DNA topoisomerase II. Experimental antitumor activity. Biochem. Pharmacol. 1992, 44, 1961–1965. [Google Scholar] [PubMed]
  59. Tanuma, S.; Johnson, L.D.; Johnson, G.S. ADP-ribosylation of chromosomal proteins and mouse mammary tumor virus gene expression. J. Biol. Chem. 1983, 258, 15371–15375. [Google Scholar] [PubMed]
  60. Aoki, K.; Nishimura, K.; Abe, H.; Maruta, H.; Sakagame, H.; Hatano, T.; Okuda, T.; Yoshida, T.; Tsai, Y.J.; Uchiumi, F.; et al. A novel inhibitors of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Acta 1993, 1158, 251–256. [Google Scholar] [CrossRef]
  61. Yoshida, T.; Haba, K.; Arata, R.; Nakata, F.; Shingu, T.; Okuda, T. Tannins and related polyphenols of Melastomataceous plants. VII. Nobotanins J and K, trimeric and tetrameric hydrolyzable tanins from Heterocentron roseum. Chem. Pharm. Bull. 1995, 43, 1101–1106. [Google Scholar] [CrossRef]
  62. Aoki, K.; Maruta, H.; Uchiumi, F.; Hatano, T.; Yoshida, T.; Tanuma, S. A macrocircular ellagitannin, oenothein B, suppresses mouse mammary tumor gene expressionvia inhibition of poly(ADP-ribose) glycohydrolase. Biochim. Biophys. Res. Commun. 1995, 210, 329–337. [Google Scholar] [CrossRef] [PubMed]
  63. Hanai, S.; Kanai, M.; Ohashi, S.; Okamoto, K.; Yamada, M.; Takahashi, H.; Miwa, M. Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 2004, 101, 82–86. [Google Scholar] [CrossRef] [PubMed]
  64. Feng, X.; Koh, D.W. Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis. Int. Rev. Cell Mol. Biol. 2013, 304, 227–281. [Google Scholar] [PubMed]
  65. Miyamoto, K.; Kishi, N.; Koshiura, R.; Yoshida, T.; Hatano, T.; Okuda, T. Relationship between the structures and the antitumor activities of tannins. Chem. Pharm. Bull. 1987, 35, 814–822. [Google Scholar] [CrossRef] [PubMed]
  66. Miyamoto, K.; Nomura, M.; Sasakura, M.; Matsui, E.; Koshiura, R.; Murayama, T.; Furukawa, T.; Hatano, T.; Yoshida, T.; Okuda, T. Antitumor activity of oenothein B, a unique macrocyclic ellagitannin. Jpn. J. Cancer Res. 1993, 84, 99–103. [Google Scholar] [CrossRef] [PubMed]
  67. Murayama, T.; Kishi, N.; Koshiura, R.; Takagi, K.; Furukawa, T.; Miyamoto, K. Agrimoniin, an antitumor tannin of Agrimonia pilosa Ledeb., induces interleukin-1. Anticancer Res. 1992, 12, 1471–1474. [Google Scholar] [PubMed]
  68. Murayama, T.; Natsuume-Sakai, S.; Ryoyama, K.; Koshiura, S. Studies on the properties of a streptococcal preparation, OK-432 (NSC-B116209), as an immunopotentiator. II. Mechanism of macrophage activation by OK-432. Cancer Immunol. Immunother. 1982, 12, 141–146. [Google Scholar] [CrossRef]
  69. Miyamoto, K.; Murayama, T.; Nomura, M.; Hatano, T.; Yoshida, T.; Furukawa, T.; Koshiura, R.; Okuda, T. Antitumor activity and interleukin-1 induction by tannins. Anticancer Res. 1993, 13, 37–42. [Google Scholar] [PubMed]
  70. Wang, C.C.; Chen, L.G.; Yang, L.L. in vitro immunomodulatory effects of cuphiin D1 on human mononuclear cells. Anticancer Res. 2002, 22, 4233–42336. [Google Scholar] [PubMed]
  71. Schepetkin, I.A.; Kirpotina, L.N.; Jarissa, L.; Khlebnikov, A.I.; Blaskovich, C.L.; Jutila, M.A.; Quinn, M.T. Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium. J. Immun. 2009, 183, 6754–6766. [Google Scholar] [CrossRef] [PubMed]
  72. Schmid, D.; Gruber, M.; Piskaty, C.; Woehs, F.; Renner, A.; Nagy, Z.; Kaltenboeck, A.; Wasserscheid, T.; Bazylko, A.; Kiss, A.K. Inhibition of NF-κB-dependent cytokine and inducible nitric oxide synthesis by the macrocyclic ellagtannin oenothein B in TLR-stimulated RAW 264.7 macrophages. J. Nat. Prod. 2012, 75, 870–875. [Google Scholar] [CrossRef] [PubMed]
  73. Chen, Y.; Yang, L.L.; Lee, T.J. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem. Pharmacol. 2000, 59, 1445–1457. [Google Scholar] [CrossRef]
  74. Ramstead, A.G.; Schepetkin, I.A.; Quinn, M.T.; Jutila, M.A. Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFNγ production by lymphocytes. PLoS ONE 2012, 7, e50546. [Google Scholar] [CrossRef] [PubMed]
  75. Ramstead, A.G.; Schepetkin, I.A.; Todd, K.; Loeffelholz, J.; Berardinelli, J.G.; Quinn, M.T.; Jutila, M.A. Aging influences the response of T cells to stimulation by the ellagitannin, oenothein B. Int. Immunopharmacol. 2015, 26, 367–377. [Google Scholar] [CrossRef] [PubMed]
  76. Yoshimura, M.; Akiyama, H.; Kondo, K.; Sakata, K.; Matsuoka, H.; Amakura, Y.; Teshima, R.; Yoshida, T. Immunological effects of oenothein B, an ellagitannin dimer, on dendritic cells. Int. J. Mol. Sci. 2013, 14, 46–56. [Google Scholar] [CrossRef] [PubMed]
  77. Yu, S.W.; Wang, H.; Poitras, M.F.; Coombs, C.; Bowers, W.J.; Federoff, H.J.; Poirier, G.G.; Dawson, T.M.; Dawson, V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297, 259–263. [Google Scholar] [CrossRef] [PubMed]
  78. Rios, L.Y.; Bennett, R.N.; Lazarus, S.A.; Rémésy, C.; Scalbert, A.; Williamson, G. Cocoa procyanidins are stable during gastric transit in humans. Am. J. Clin. Nutr. 2002, 76, 1106–1110. [Google Scholar] [CrossRef] [PubMed]
  79. Okuyama, S.; Makihata, N.; Yoshimura, M.; Amakura, Y.; Yoshida, T.; Nakajima, M.; Furukawa, Y. Oenothein B suppresses lipopolysaccharide (LPS)-induced inflammation in the mouse brain. Int. J. Mol. Sci. 2013, 14, 9767–9778. [Google Scholar] [CrossRef] [PubMed]
  80. O’Connor, J.C.; Lawson, M.A.; André, C.; Moreau, M.; Lestage, J.; Castanon, N.; Kelley, K.W.; Dantzer, R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 2009, 14, 511–522. [Google Scholar] [CrossRef] [PubMed]
  81. Ito, H.; Iguchi, A.; Hatano, T. Identification of urinary and intestinal bacterial metabolites of ellagitannin geraniin in rats. J. Agric. Food Chem. 2008, 56, 393–400. [Google Scholar] [CrossRef] [PubMed]
  82. Giménez-Bastida, J.A.; Larrosa, M.; González-Sarrías, A.; Tomás-Barberán, F.; Espín, J.C.; García-Conesa, M.T. Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts. J. Agric. Food Chem. 2012, 60, 8866–8876. [Google Scholar] [CrossRef] [PubMed]
  83. Kolodziej, H.; Kayser, O.; Latte, K.P.; Kiderlen, A.F. Enhancement of antimicrobial activity of tannins and related compounds by immune modulatory effects. In Plant Polyphenols 2; Gross, G.G., Hemingway, R.W., Yoshida, T., Eds.; Kluwer Academic/Plenum Publishers: New York, NY, USA, 1999; pp. 575–594. [Google Scholar]
  84. Kolodziej, H.; Kayser, O.; Latte, K.P.; Kiderlen, A.F.; Ito, H.; Hatano, T.; Yoshida, T.; Foo, L.Y. Antileishmanial activity of hydrolysable tannins and their modulatory effects on nitric oxide and tumor necrosis factor-a release in macrophages in vitro. Planta Med. 2001, 67, 825–832. [Google Scholar] [CrossRef] [PubMed]
  85. Hatano, T.; Tsugawa, M.; Ohyabu, T.; Kusuda, M.; Shiota, S.; Tsuchiya, T.; Yoshida, T. Effects of polyphenols in tea and foods on methicillin-resistant Staphylococcus aureus and the sustainability of the antibacterial effects in the presence of food additives. Assoc. J. Jpn. Soc. Med. Use Funct. Foods 2006, 4, 43–48. [Google Scholar]
  86. Ishimoto, H.; Shibata, M.; Myojin, Y.; Ito, H.; Sugimoto, Y.; Tai, A.; Hatano, T. in vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A. Bioorg. Med. Chem. Lett. 2011, 21, 5901–5904. [Google Scholar] [CrossRef] [PubMed]
  87. Tomas-Barberan, F.A.; Espin, J.C.; Garcia-Conesa, M.T. Bioavailability and metabolism of ellagic acid and ellagitannins. In Chemisty and Biology of Ellagitannins; Quideau, S., Ed.; World Scientific: Hackensack, NJ, USA, 2009; pp. 273–297. [Google Scholar]
  88. Torronen, R. Sources and health effects of dietry ellagitannins. In Chemisty and Biology of Ellagitannins; Quideau, S., Ed.; World Scientific: Hackensack, NJ, USA, 2009; pp. 298–319. [Google Scholar]
  89. Lan, Y.; Wang, L.; Cao, S.; Zhong, Y.; Li, Y.; Cao, Y.; Zhao, L. Rational design of food-grade polyelectrolyte complex coacervate for encapsulation and enhanced oral delivery of oenothein B. Food Funct. 2017, 8, 4070–4080. [Google Scholar] [CrossRef] [PubMed]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.